Luxembourg Institute of Health


The Luxembourg Institute of Health (LIH) is a public biomedical research organisation focused on precision health and invested in becoming a leading reference in Europe for the translation of scientific excellence into meaningful benefits for patients.  

LIH places the patient at the heart of all its activities, driven by a collective obligation towards society to use knowledge and technology arising from research on patient-derived data to have a direct impact on people’s health. Its dedicated teams of multidisciplinary researchers strive for excellence, generating relevant knowledge linked to immune related diseases and cancer.  

The institute embraces collaborations, disruptive technology and process innovation as unique opportunities to improve the application of diagnostics and therapeutics with the long-term goal of preventing disease. 

LIH aims to perform research that transcends the boundaries of classical disease definition. Its translational and transversal research strategy, combined with the increasing appreciation of the role of the immune system in determining disease, has led LIH to focus on two priority areas, with inflammation and immunity as the common thread: cancer and immunological disorders.

Last updated : June 28, 2023